Tanacetum parthenium (Asteraceae) Feverfew, Featherfew

Tanacetum parthenium, commonly known as feverfew, is one of the most scientifically validated herbal remedies for the prevention of migraine headaches. This perennial herb from the Asteraceae family has been used since ancient Greek times for fever and inflammation, with its modern renaissance emerging from a documented case of self-medication by a Welsh woman who found relief from her severe migraines. The plant's therapeutic reputation is anchored by parthenolide, a sesquiterpene lactone that serves as its primary bioactive marker and pharmacological cornerstone. Beyond migraine prophylaxis, contemporary research has revealed its potent anti-inflammatory, neuromodulatory, anticancer, and emerging antiparasitic properties, positioning it as a versatile medicinal agent with applications spanning neurology, oncology, and infectious disease.

---

1. Taxonomic Insights

Species: Tanacetum parthenium (L.) Sch.Bip.

Family: Asteraceae (Compositae)

Taxonomic Note: The species was originally described as Matricaria parthenium by Linnaeus in 1753. Its current accepted name, Tanacetum parthenium, was established by Schultz Bipontinus in 1844. The genus name Tanacetum is derived from the Latin "tanazetein," meaning immortal, possibly referring to the long-lasting flowers. The specific epithet parthenium comes from the Greek "parthenios," meaning maiden or virgin, a reference to its traditional use in treating gynecological conditions.

The Asteraceae family is one of the largest families of flowering plants, characterized by composite flower heads that resemble a single flower but are actually inflorescences of many small florets. This family is medicinally significant for its diverse array of sesquiterpene lactones, flavonoids, and essential oils.

Related Herbs from the Same Family:

· Tanacetum vulgare (Tansy): A close relative with similar sesquiterpene lactone content, traditionally used as an anthelmintic and emmenagogue, though more toxic than feverfew.

· Chrysanthemum parthenium: An older synonym, this reflects the plant's ornamental cultivation as a garden chrysanthemum.

· Matricaria chamomilla (German Chamomile): A fellow Asteraceae member with overlapping anti-inflammatory and antispasmodic properties, though chamomile is gentler and better suited for acute anxiety and digestive complaints.

· Artemisia annua (Sweet Wormwood): Another Asteraceae species with sesquiterpene lactone bioactivity, renowned for artemisinin in malaria treatment.

· Arnica montana (Arnica): Contains similar sesquiterpene lactones with potent anti-inflammatory effects, though arnica is strictly for topical use due to toxicity.

---

2. Common Names

Scientific Name: Tanacetum parthenium | English: Feverfew, Featherfew, Bachelor's Buttons, Wild Chamomile, Midsummer Daisy | French: Grande Camomille, Partenelle |

---

3. Medicinal Uses

Primary Actions: Antimigraine, Anti-inflammatory, Analgesic, Antipyretic, Immunomodulatory, Antispasmodic, Vasodilator.

Secondary Actions: Anticancer, Antiparasitic (trypanocidal, leishmanicidal), Antioxidant, Antidiabetic, Antiemetic (mild), Emmenagogue.

Medicinal Parts:

The leaves and flowering tops are the primary medicinal parts, though recent research has characterized the distinct phytochemical profiles of all organs.

· Leaves: The most commonly used part in traditional preparations and modern extracts. They contain the highest total flavonoid and phenolic content, with 1.07 mg quercetin equivalent per gram for flavonoids and 22.19 mg gallic acid equivalent per gram for total phenolics.

· Flowers: Contain the highest essential oil content at 1.75% and the highest parthenolide concentration at 1.09 mg per gram dry weight, making them the preferred source for standardized extracts.

· Aerial Parts (Flowering Tops): Traditionally harvested when the plant is in full flower for optimal bioactive content.

· Roots: Contain the lowest parthenolide content at 0.08 mg per gram but demonstrate significant antioxidant activity (76.67% inhibition), suggesting distinct bioactive profiles.

---

4. Phytochemicals Specific to the Plant and Their Action

Sesquiterpene Lactones (Primary Bioactive Class)

· Parthenolide: The signature bioactive compound and chemical marker of the species. This sesquiterpene lactone with a germacrene skeleton is responsible for the majority of feverfew's pharmacological effects. It exhibits Anti-inflammatory activity through inhibition of NF-κB and COX-2, Antimigraine effects by modulating serotonin and dopamine pathways, Analgesic properties, and Anticancer activity by inducing apoptosis in various cancer cell lines. Parthenolide content varies significantly across plant organs, with flowers containing the highest concentration.

· Epoxyparthenolide: The major oxidative metabolite formed during hepatic metabolism via the cytochrome P-450 system. This compound retains biological activity and has shown trypanocidal and leishmanicidal effects.

· Other Sesquiterpenes: Costunolide, santamarine, and other germacranolide derivatives contribute to the overall bioactivity.

Essential Oil Constituents

· Farnesol (36.31%): The dominant essential oil constituent with documented Antioxidant, Anti-inflammatory, and Antimicrobial properties. It contributes to the plant's overall therapeutic profile.

· Bornyl Acetate (26.18%): A monoterpene ester with Antispasmodic and Sedative properties.

· Spathulenol (24.38%): A tricyclic sesquiterpene alcohol with Antioxidant, Anti-inflammatory, and Antihypertensive effects.

· Camphor (20.36%): A monoterpene ketone with topical Analgesic, Antipruritic, and mild Expectorant properties.

· Z-Spiroether (19.3%): A unique polyacetylene derivative with Immunomodulatory activity.

· Bornyl Angelate (17.07%) and Neo-intermedeol (16.44%): Additional sesquiterpenoids contributing to the essential oil's bioactivity.

· Borneol (12.96%): A bicyclic monoterpene with Analgesic, Anti-inflammatory, and Neuroprotective properties.

Flavonoids

· Luteolin and Luteolin-7-O-glucoside: Potent Antioxidant flavonoids that contribute to Anti-inflammatory effects by modulating NF-κB and inhibiting COX-2. They may also modulate pain pathways and contribute to the antimigraine effect.

· Quercetin Derivatives: Provide Antioxidant, Anti-inflammatory, and Mast-cell stabilizing activities.

· Apigenin: A flavonoid with Anxiolytic, Anti-inflammatory, and Chemopreventive properties.

Other Bioactive Compounds

· Beta-Caryophyllene: A bicyclic sesquiterpene that acts as a selective cannabinoid receptor type 2 agonist, providing Anti-inflammatory, Analgesic, and Anxiolytic effects through this distinct mechanism.

· Phenolic Compounds: Total phenolic content in leaves reaches 22.19 mg gallic acid equivalent per gram, contributing significant Antioxidant capacity with DPPH radical scavenging ranging from 62.28% to 76.67% across organs.

· Anthocyanins: Present at 0.107 mg per gram in leaf extracts, contributing to Antioxidant activity.

· Melatonin: Naturally occurring in feverfew, contributing to Sleep regulation and Antioxidant protection.

---

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

Headache and Migraine (Primary Traditional Indication)

Formulation: Dried leaf infusion, fresh leaf consumption, or standardized extract.

Preparation & Use: Among Germanic peoples, dried feverfew leaves were boiled into a decoction to relieve throbbing headaches and calm the nervous system. The traditional method involves steeping 1 teaspoon of dried leaves in 1 cup of boiling water for 5 to 10 minutes, consumed 2 to 3 cups daily. Alternatively, fresh leaves were sometimes eaten in a sandwich, though this is not recommended due to potential oral ulceration.

Reasoning: Parthenolide and other bioactive compounds modulate serotonin and dopamine pathways, inhibit prostaglandin synthesis, and prevent the vasodilation and neuroinflammation associated with migraine pathophysiology. Modern meta-analyses confirm significant reduction in migraine attack frequency with standardized extracts.

Fever (Historical Primary Indication)

Formulation: Leaf decoction or infusion.

Preparation & Use: The herb's very name derives from its traditional use in reducing fevers, documented since Dioscorides' Materia Medica. A warm infusion was consumed to induce sweating and break fevers.

Reasoning: The antipyretic action is mediated through inhibition of prostaglandin synthesis and modulation of hypothalamic thermoregulatory pathways, mechanisms shared with its anti-inflammatory effects.

Rheumatic Pain and Arthritis

Formulation: Leaf infusion for internal use; poultice for topical application.

Preparation & Use: In the British Isles, folk healers gave a mild infusion to soldiers suffering from rheumatic pain. The Bedouin of the Arabian Peninsula prepared a poultice of crushed leaves applied to the temples and joints to ease arthritis.

Reasoning: The anti-inflammatory effects of parthenolide, luteolin, and beta-caryophyllene reduce joint inflammation and pain through NF-κB inhibition, COX-2 suppression, and cannabinoid receptor activation.

Menstrual Cramps and Gynecological Conditions

Formulation: Mild leaf infusion.

Preparation & Use: British folk healers recorded in 1920 that a mild infusion was given to women suffering from menstrual cramps. The name parthenium, meaning maiden, reflects this traditional gynecological application.

Reasoning: The antispasmodic properties of bornyl acetate and the anti-inflammatory effects of parthenolide help reduce uterine smooth muscle contraction and pelvic inflammation.

Digestive Disorders

Formulation: Bitter infusion or tincture.

Preparation & Use: Traditionally used as a bitter tonic to stimulate digestion and relieve colic, reflecting the broader Asteraceae family's digestive applications.

Reasoning: Bitter principles stimulate gastric secretion and bile flow, while antispasmodic compounds relax gastrointestinal smooth muscle.

---

6. Healing Recipes, Decoctions, and Preparations

Traditional Feverfew Tea

Purpose: Migraine prevention and general anti-inflammatory support.

Preparation & Use:

1. Take 1 teaspoon (approximately 2 grams) of dried feverfew leaves.

2. Steep in 1 cup (240 ml) of boiling water for 5 to 10 minutes.

3. Strain and drink 2 to 3 cups daily, preferably before meals. The tea's mild bitterness is characteristic of the herb's natural compounds.

Fresh Leaf Caution: While traditional use includes eating fresh leaves, this practice can cause oral ulceration and contact dermatitis in sensitive individuals. Dried preparations or standardized extracts are generally preferred.

Standardized Extract Supplement

Purpose: Consistent dosing for migraine prophylaxis.

Preparation & Use: Commercial standardized extracts typically contain 0.2% to 0.5% parthenolide. The clinically studied dosage ranges from 50 to 150 mg of extract daily, standardized to 0.2% parthenolide. Always follow manufacturer guidelines and consult a healthcare professional.

Anti-inflammatory Poultice

Purpose: Topical application for joint pain, arthritis, and localized inflammation.

Preparation & Use:

1. Crush fresh feverfew leaves to form a paste.

2. Apply directly to the affected joint or area, cover with a clean cloth.

3. Leave for 20 to 30 minutes, then rinse. Patch test first to check for skin sensitivity.

Cold Maceration for Sensitive Stomachs

Purpose: Milder preparation for those who find the hot infusion too bitter or irritating.

Preparation & Use:

1. Place 2 teaspoons of dried leaves in 1 cup of cold water.

2. Steep for 8 to 12 hours at room temperature.

3. Strain and drink. This method extracts water-soluble compounds while minimizing extraction of more irritating constituents.

---

7. In-Depth Phytochemical Profile and Clinical Significance of Tanacetum parthenium (Feverfew)

Introduction

Tanacetum parthenium, known to herbalists as feverfew, represents a remarkable convergence of ancient folk wisdom and rigorous modern pharmacology. From its documented use by the Greek physician Dioscorides to the serendipitous case in 1970s Wales that sparked its modern renaissance as a migraine remedy, this unassuming herb has earned its place among the most scientifically validated medicinal plants. Its therapeutic prominence is anchored by parthenolide, a sesquiterpene lactone that has become a model compound for understanding how natural products can modulate inflammation, neurotransmission, and cellular survival pathways. But the plant's pharmacological depth extends far beyond this single molecule. Recent research has illuminated its complex essential oil chemistry, the organ-specific distribution of bioactive compounds that informs sustainable harvesting practices, and its emerging potential in oncology and neglected tropical diseases. The 2025 to 2026 period has been particularly fruitful, with a meta-analysis confirming clinical efficacy in migraine prevention, a mechanistic study revealing the synergy between parthenolide and salicin in blocking central sensitization, and the discovery of significant antiparasitic activity against trypanosomes and leishmania.

1. Parthenolide: The Signature Sesquiterpene Lactone

Key Compound: Parthenolide, a germacranolide-type sesquiterpene lactone.

Quantitative Profile: Parthenolide content varies significantly by plant organ. Flowers contain the highest concentration at 1.09 mg per gram dry weight, followed by leaves at intermediate levels, with roots containing the lowest at 0.08 mg per gram. This organ-specific distribution has significant implications for quality control and sustainable pharmaceutical manufacturing.

Actions and Clinical Relevance:

· Anti-inflammatory (Primary Mechanism): Parthenolide exerts its potent anti-inflammatory effects primarily through inhibition of the transcription factor NF-κB, a master regulator of inflammatory gene expression. By blocking the activation of this pathway, parthenolide suppresses the production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, as well as the inducible form of cyclooxygenase (COX-2). This mechanism explains the herb's traditional use across a broad spectrum of inflammatory conditions from arthritis to gastrointestinal inflammation.

· Antimigraine (Clinically Validated): A landmark 2026 study published in Pain investigated the effects of parthenolide in combination with salicin (from white willow) on migraine pathophysiology. The research demonstrated that the combination prevented both chronic ictal and interictal cephalic mechanical hypersensitivity in animal models, as well as the inflammatory soup-induced increase in CGRP immunoreactivity within the trigeminocervical complex. The combination exerted its preventive effect by blocking afferent inputs from the dura during the induction phase, thereby preventing the establishment of central sensitization. This mechanistic insight explains why feverfew is effective for migraine prevention rather than acute abortive treatment.

· Neuromodulatory: A 2020 study on feverfew water extract revealed that parthenolide directly interacts with the dopamine transporter, decreasing extracellular dopamine levels and increasing dopamine transporter gene expression in hypothalamic cells. This modulation of the dopaminergic system, combined with reduced cortical PGE2 release and decreased IL-1β expression, supports its role in managing the complex neurovascular and neurochemical disturbances underlying migraine.

· Anticancer (Extensively Researched): Parthenolide has demonstrated significant anticancer activity across multiple cancer cell lines through mechanisms including NF-κB inhibition, induction of apoptosis, and selective cytotoxicity against cancer stem cells. Its ability to enhance the effect of conventional chemotherapeutic agents such as cyclophosphamide has been documented, suggesting potential as an adjunctive therapy. The compound also exhibits collateral sensitivity in drug-resistant cancer cell lines, a property of significant clinical relevance.

· Antiparasitic (2025 Discovery): A 2025 study in the Journal of the Brazilian Chemical Society evaluated parthenolide and its major metabolite epoxyparthenolide for trypanocidal and leishmanicidal activity. Parthenolide demonstrated significant cytotoxic effects against both parasites, with mean inhibitory concentration values that hold promise for addressing these neglected tropical diseases. This represents a new frontier in feverfew research beyond its traditional indications.

2. Essential Oil Constituents: The Complementary Bioactive Matrix

Key Compounds: Farnesol (36.31%), Bornyl acetate (26.18%), Spathulenol (24.38%), Camphor (20.36%), Z-Spiroether (19.3%), Bornyl angelate (17.07%), Neo-intermedeol (16.44%), Borneol (12.96%).

Quantitative Profile: Essential oil content varies by organ, with flowers containing the highest concentration at 1.75%. The oil composition is remarkably consistent across aerial parts, though concentrations of individual constituents vary.

Actions and Clinical Relevance:

· Farnesol: As the dominant essential oil constituent, farnesol contributes significant anti-inflammatory and antioxidant activity. Its presence in high concentration reinforces the overall anti-inflammatory profile of the whole herb.

· Spathulenol: This tricyclic sesquiterpene alcohol has documented antihypertensive effects, which may contribute to the vasodilatory actions relevant to migraine pathophysiology. It also exhibits significant antioxidant and anti-inflammatory properties.

· Camphor and Borneol: These bicyclic monoterpenes provide mild topical analgesic effects through TRPV1 channel modulation. When present in the essential oil, they contribute to the sensory experience of the herb and may enhance its topical applications.

· Beta-Caryophyllene: As a selective cannabinoid receptor type 2 agonist, this compound provides anti-inflammatory and analgesic effects through a mechanism entirely distinct from parthenolide, demonstrating the multi-target synergy inherent in the whole herb.

3. Flavonoids and Phenolic Compounds: The Antioxidant Foundation

Key Compounds: Luteolin, Luteolin-7-O-glucoside, Quercetin derivatives, Apigenin, Total phenolics (22.19 mg gallic acid equivalent per gram in leaves).

Quantitative Profile: Total phenolic content in leaves reaches 22.19 mg gallic acid equivalent per gram, while total flavonoid content is 1.07 mg quercetin equivalent per gram. Anthocyanin content is 0.107 mg per gram. Antioxidant activity, measured by DPPH radical scavenging, ranges from 62.28% in leaves to 76.67% in roots and flowers.

Actions and Clinical Relevance:

· Antioxidant: The flavonoid and phenolic matrix provides robust protection against oxidative stress, complementing the anti-inflammatory effects of parthenolide. This antioxidant capacity is particularly relevant in migraine pathophysiology, where oxidative stress contributes to both the initiation and propagation of cortical spreading depression.

· Anti-inflammatory Synergy: Luteolin and apigenin inhibit NF-κB and COX-2 through pathways that complement those of parthenolide, creating a synergistic anti-inflammatory effect that exceeds the sum of individual contributions.

· Neuromodulatory: Flavonoids have documented effects on GABAergic and serotonergic systems, potentially contributing to the overall antimigraine effect through modulation of central neurotransmitter balance.

4. Organ-Specific Distribution: Implications for Sustainable Pharmaceutical Manufacturing

Recent 2025 Research: A comprehensive study published in 2025 characterized the metabolite distribution across feverfew organs, revealing distinct profiles that inform sustainable harvesting and manufacturing practices.

· Flowers: Optimal for parthenolide extraction (1.09 mg/g) and essential oil production (1.75% yield). The high concentration of bioactive compounds in flowers, which are renewable and non-destructive to harvest, suggests that flower-based extracts may be preferable to leaf-based preparations for sustainability.

· Leaves: Highest in total flavonoids (1.07 mg/g) and total phenolics (22.19 mg/g), making them optimal for antioxidant-rich preparations. The leaves also contain the highest anthocyanin content.

· Roots: Lowest parthenolide content but demonstrate the highest percentage of DPPH radical scavenging (76.67%), indicating a distinct bioactive profile that warrants further investigation.

· Sustainable Manufacturing: The finding that different organs concentrate different bioactive compounds allows for targeted production of extracts optimized for specific therapeutic applications, reducing waste and improving sustainability in pharmaceutical manufacturing.

An Integrated View of Healing in Tanacetum parthenium

· For Migraine Prophylaxis (Clinically Validated): Feverfew represents one of the most thoroughly investigated herbal medicines for migraine prevention. The 2025 to 2026 meta-analysis of nine randomized controlled trials involving 899 participants provides the strongest evidence to date: feverfew significantly reduced migraine attack frequency with a mean difference of -1.11 attacks and demonstrated significant reduction in migraine duration. While effects on pain severity and associated symptoms were less pronounced, the evidence supports its role as a preventive intervention. The 2026 mechanistic study elucidates how this effect occurs: the combination of parthenolide and salicin prevents central sensitization by blocking afferent inputs from the dura during the induction phase, stopping the cascade before chronic pain is established.

· For Inflammatory Conditions: The anti-inflammatory effects operate at multiple levels simultaneously. Parthenolide inhibits NF-κB, the master switch of inflammation. Flavonoids like luteolin provide complementary COX-2 inhibition. Beta-caryophyllene activates cannabinoid receptor type 2, providing analgesia and anti-inflammation through an entirely distinct pathway. This multi-target approach, characteristic of effective herbal medicines, provides comprehensive inflammatory control without the side effects associated with selective pharmaceutical interventions.

· For Neurological and Neuroinflammatory Disorders: Beyond migraine, feverfew's modulation of dopamine and serotonin pathways, combined with its anti-neuroinflammatory effects, suggests potential applications in other neurological conditions. The reduction in PGE2 and IL-1β observed in cortical tissue, combined with increased BDNF expression, supports its potential in conditions involving neuroinflammation and impaired neuroplasticity.

· For Cancer Support (Emerging Application): Parthenolide's ability to induce apoptosis in cancer cells while sensitizing them to conventional chemotherapeutics positions feverfew as a potential adjunctive therapy. Its activity against cancer stem cells and effectiveness in drug-resistant cell lines are particularly promising. The 2025 discovery that parthenolide's major metabolite epoxyparthenolide retains antiparasitic activity further expands its therapeutic horizon.

· As a Sustainable Pharmaceutical Resource: The 2025 organ-specific profiling study transforms feverfew from a simple garden herb into a model for sustainable pharmaceutical manufacturing. By understanding that flowers optimize parthenolide yield, leaves optimize antioxidant content, and roots possess distinct bioactivity, manufacturers can target harvest to specific therapeutic goals, reducing waste and ensuring consistent, high-quality extracts.

Safety and Adverse Effects

Feverfew is generally well-tolerated when used appropriately. However, several safety considerations warrant attention:

· Oral Mucosal Effects: Chewing fresh leaves can cause oral ulceration, swelling, and numbness of the mouth. This is a local effect and does not contraindicate use of dried or extract forms.

· Contact Dermatitis: Handling fresh plants may cause skin reactions in sensitive individuals.

· Pregnancy and Lactation: Feverfew has emmenagogue properties and may stimulate uterine contractions. It should be avoided during pregnancy. Safety during breastfeeding has not been established.

· Drug Interactions: Due to its antiplatelet effects (inhibiting serotonin release from platelets), feverfew may potentiate anticoagulant medications including warfarin, aspirin, and other blood thinners. It should be discontinued before elective surgery.

· Withdrawal: Abrupt discontinuation after long-term use has been associated with a rebound syndrome characterized by headache, anxiety, and muscle stiffness. Gradual tapering is recommended when discontinuing therapy.

· Allergy: Individuals with known allergies to Asteraceae plants (ragweed, chamomile, marigold, echinacea) may experience cross-sensitivity.

Conclusion: Tanacetum parthenium stands as a model of how traditional botanical knowledge can be validated, refined, and expanded through rigorous scientific investigation. From its ancient use in fever and inflammation to its modern role as a first-line herbal preventive for migraine, the plant has maintained therapeutic relevance across millennia. The 2025 to 2026 period has been particularly transformative, with a meta-analysis confirming clinical efficacy across nine trials, a mechanistic study illuminating how parthenolide and salicin prevent central sensitization, organ-specific profiling enabling sustainable pharmaceutical manufacturing, and the discovery of significant antiparasitic activity opening new frontiers. The plant's pharmacological depth arises from the synergy between its signature sesquiterpene lactone, its complex essential oil constituents, and its flavonoid matrix, creating a multi-target therapeutic agent that addresses the complex pathophysiology of migraine, inflammation, and beyond. As research continues to reveal new applications and refine our understanding of its mechanisms, feverfew promises to remain a cornerstone of evidence-based phytotherapy.

---

Disclaimer:

Feverfew is generally considered safe for short-term use in recommended doses. However, individuals with allergies to plants in the Asteraceae family (ragweed, chamomile, echinacea) should exercise caution. Pregnant and breastfeeding women should avoid use. Those taking anticoagulant or antiplatelet medications should consult a healthcare provider before use due to potential additive effects. Long-term use should be tapered gradually to avoid rebound symptoms. Fresh leaves should not be chewed due to risk of oral ulceration. This information is for educational purposes only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· Herbal Medicine: Biomolecular and Clinical Aspects by Iris F.F. Benzie and Sissi Wachtel-Galor

· The Complete German Commission E Monographs by Mark Blumenthal

· Medical Herbalism: The Science and Practice of Herbal Medicine by David Hoffmann

· Principles and Practice of Phytotherapy by Kerry Bone and Simon Mills

· The Essential Guide to Herbal Safety by Simon Mills and Kerry Bone

---

9. Further Study: Plants That Might Interest You Due to Similar Medicinal Properties

*1. Salix alba (White Willow)

· Species: Salix alba | Family: Salicaceae

· Similarities: The 2026 combination study demonstrating synergy between parthenolide and salicin highlights the complementary mechanisms of these two classic anti-inflammatory herbs. While feverfew targets NF-κB and dopamine pathways, white willow provides salicin that converts to salicylic acid, inhibiting COX enzymes. Together they prevent central sensitization in migraine, representing a powerful example of rational herbal combination.

*2. Petasites hybridus (Butterbur)

· Species: Petasites hybridus | Family: Asteraceae

· Similarities: Alongside feverfew, butterbur is one of the most clinically validated herbal medicines for migraine prevention. Both are Asteraceae members with anti-inflammatory mechanisms targeting leukotrienes and prostaglandins. While butterbur requires processing to remove hepatotoxic pyrrolizidine alkaloids, feverfew has a superior safety profile for long-term use.

*3. Tanacetum vulgare (Tansy)

· Species: Tanacetum vulgare | Family: Asteraceae

· Similarities: A close congener with similar sesquiterpene lactone chemistry. Tansy shares feverfew's anti-inflammatory and anthelmintic properties but is significantly more toxic due to higher thujone content. It serves as a cautionary example of how related species can have vastly different safety profiles.

*4. Zingiber officinale (Ginger)

· Species: Zingiber officinale | Family: Zingiberaceae

· Similarities: Ginger shares with feverfew a role in migraine prevention through inhibition of COX and lipoxygenase pathways, modulation of serotonin, and anti-inflammatory effects. The combination of ginger and feverfew is sometimes used synergistically for migraine and inflammatory conditions.

-x-x-x-End-x-x-x-